Cancer, whether in the pancreas or in the liver, can take on
different characteristics and spread in different ways. That's why, there's no
one-size-fits-all drug to help patients fight back.
But a new test can personalize treatment and help oncologists choose which chemotherapy route to take. The test, called Dynamic BH3 Profiling, quickly predicts whether or not a drug will work for a patient by first trying that drug on a tumor sample in the lab.
A paper describing the method, which researchers say could become more widespread within a couple of years, was published in the journal Cell this week.